Results 201 to 210 of about 823,941 (253)

Mycophenolate Mofetil Treatment Reduces the Risk of Treatment Escalation Due to Vascular Complications in Limited Cutaneous Systemic Sclerosis: Emulation of a Target Trial From the Italian Rheumatology Society SPRING Registry

open access: yesArthritis Care &Research, EarlyView.
Objective Mycophenolate mofetil (MMF) use in limited cutaneous systemic sclerosis (lcSSc) is relatively uncommon because of the lower fibrotic burden and the predominance of vascular complications. In vitro observations and clinical data from transplanted patients suggest a protective effect of MMF on endothelial function.
Enrico De Lorenzis   +77 more
wiley   +1 more source

A Lethal Progressive Neuroinflammation Disguised as MOGAD Revealing a Final Diagnosis of Griscelli Syndrome

open access: yes
Annals of Clinical and Translational Neurology, EarlyView.
Chiara Veredice   +4 more
wiley   +1 more source

Reply to: A Lethal Progressive Neuroinflammation Disguised as MOGAD Revealing a Final Diagnosis of Griscelli Syndrome

open access: yes
Annals of Clinical and Translational Neurology, EarlyView.
Chaitanya Aduru   +13 more
wiley   +1 more source

Editorial: Radiomics and AI for clinical and translational medicine. [PDF]

open access: yesFront Radiol
Montin E   +4 more
europepmc   +1 more source

Videofluoroscopy of the aerodigestive tract in Phoca vitulina: reshaping perspectives on translational medicine. [PDF]

open access: yesFront Vet Sci
Skoretz SA   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy